Steg P G, Cambou J-P, Goldstein P, Durand E, Sauval P, Kadri Z, Blanchard D, Lablanche J-M, Guéret P, Cottin Y, Juliard J-M, Hanania G, Vaur L, Danchin N
Department of Cardiology, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France.
Heart. 2006 Oct;92(10):1378-83. doi: 10.1136/hrt.2006.101972. Epub 2006 Aug 16.
To study the impact on outcomes of direct admission versus emergency room (ER) admission in patients with ST-segment elevation myocardial infarction (STEMI) DESIGN: Nationwide observational registry of STEMI patients
369 intensive care units in France.
Patients were categorised on the basis of the initial management pathway (direct transfer to the coronary care unit or catheterisation laboratory versus transfer via the ER).
Delays between symptom onset, admission and reperfusion therapy. Mortality at five days and one year.
Of 1204 patients enrolled, 66.9% were admitted direct and 33.1% via the ER. Bypassing the ER was associated with more frequent use of reperfusion (61.7% v 53.1%; p = 0.001) and shorter delays between symptom onset and admission (244 (interquartile range 158) v 292 (172) min; p < 0.001), thrombolysis (204 (150) v 258 (240) min; p < 0.01), hospital thrombolysis (228 (156) v 256 (227) min, p = 0.22), and primary percutaneous coronary intervention (294 (246) v 402 (312) min; p < 0.005). Five day mortality rates were lower in patients who bypassed the ER (4.9% v 8.6%; p = 0.01), regardless of the use and type of reperfusion therapy. After adjusting for the simplified Thrombolysis in Myocardial Infarction (TIMI) risk score, admission via the ER was an independent predictor of five day mortality (odds ratio 1.67, 95% confidence interval 1.01 to 2.75).
In this observational analysis, bypassing the ER was associated with more frequent and earlier use of reperfusion therapy, and with an apparent survival benefit compared with admission via the ER.
研究直接入院与急诊室(ER)入院对ST段抬高型心肌梗死(STEMI)患者治疗结果的影响
STEMI患者的全国性观察性登记研究
法国369个重症监护病房
根据初始治疗途径对患者进行分类(直接转至冠心病监护病房或导管室与经急诊室转至上述科室)
症状发作、入院与再灌注治疗之间的延迟时间。五天和一年时的死亡率
在纳入的1204例患者中,66.9%直接入院,33.1%经急诊室入院。绕过急诊室与更频繁地使用再灌注治疗相关(61.7%对53.1%;p = 0.001),且症状发作至入院之间的延迟时间更短(244(四分位间距158)分钟对292(172)分钟;p < 0.001),溶栓治疗延迟时间更短(204(150)分钟对258(240)分钟;p < 0.01),院内溶栓延迟时间更短(228(156)分钟对256(227)分钟,p = 0.22),以及直接经皮冠状动脉介入治疗延迟时间更短(294(246)分钟对402(312)分钟;p < 0.005)。绕过急诊室的患者五天死亡率更低(4.9%对8.6%;p = 0.01),无论再灌注治疗的使用情况和类型如何。在对简化的心肌梗死溶栓(TIMI)风险评分进行校正后,经急诊室入院是五天死亡率的独立预测因素(比值比1.67,95%置信区间1.01至2.75)。
在这项观察性分析中,绕过急诊室与更频繁、更早地使用再灌注治疗相关,且与经急诊室入院相比有明显的生存获益。